BioArctic develops new treatment for Gaucher's disease |
| November 08, 2022 | November 2022 Bond Updates |
|
STOCKHOLM, Nov. 8, 2022 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today announced that the company has initiated a new project focused on enzyme replacement therapy for Gaucher's disease in combination with the company's Brain Transporter technology. Today there is no... |
| View more at: https://www.prnewswire.com:443/news-releases/bioarctic-develops-new-treatment-for-gauchers-disease-301671247.html |
| Related News |
|